Biomarin Pharmaceutical (BMRN) Interest Coverage Ratio (2009 - 2026)
Biomarin Pharmaceutical (BMRN) recorded quarterly Interest Coverage Ratio of 8.67 in Q1 2026, up 153.97% on a QoQ basis from 16.06 in Q4 2025, and down 88.92% year-over-year from 78.2 in Q1 2025.
Biomarin Pharmaceutical (BMRN) Interest Coverage Ratio (2009 - 2026) Analysis & Trends
Biomarin Pharmaceutical has disclosed Interest Coverage Ratio across 18 years of filings, most recently posting 8.67 for Q1 2026.
- Quarterly Interest Coverage Ratio fell 88.92% year-over-year to 8.67 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 13.71 (down 73.49% YoY) and the FY2025 annual result came in at 37.57, down 1.72% from the prior year.
- Interest Coverage Ratio climbed to 8.67 in Q1 2026, from 16.06 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 103.35 in Q2 2025 and troughed at 18.1 in Q3 2025.
- A 5-year average of 23.8 and a median of 16.85 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio jumped 1663.71% — and 2025, when it slumped 147.18%.
- Tracing BMRN's Interest Coverage Ratio over 5 years: stood at 3.61 in 2022, then soared by 223.94% to 4.47 in 2023, then soared by 1300.13% to 62.63 in 2024, then sank by 125.64% to 16.06 in 2025, then surged by 153.97% to 8.67 in 2026.
- Business Quant data shows BMRN's Interest Coverage Ratio at 8.67 in Q1 2026, 16.06 in Q4 2025, and 18.1 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Biomarin Pharmaceutical | 10.52 Bn | 8.29 Bn | 571.21 Mn | 8.67 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.67 |
| Dec 31, 2025 | -16.06 |
| Sep 30, 2025 | -18.10 |
| Jun 30, 2025 | 103.35 |
| Mar 31, 2025 | 78.20 |
| Dec 31, 2024 | 62.63 |
| Sep 30, 2024 | 38.37 |
| Jun 30, 2024 | 33.70 |
| Mar 31, 2024 | 24.94 |
| Dec 31, 2023 | 4.47 |
| Sep 30, 2023 | 8.08 |
| Jun 30, 2023 | 17.46 |
| Mar 31, 2023 | 16.85 |
| Dec 31, 2022 | -3.61 |
| Sep 30, 2022 | -0.52 |
| Jun 30, 2022 | 10.15 |
| Mar 31, 2022 | 36.08 |
| Dec 31, 2021 | -17.13 |
| Sep 30, 2021 | -13.75 |
| Jun 30, 2021 | 3.06 |